Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dietary Supplement Education Campaign Features Web Site, Monthly Articles

This article was originally published in The Tan Sheet

Executive Summary

The Dietary Supplement Information Bureau's Web site will post a monthly commentary addressing various aspects of dietary supplements starting in early September.

You may also be interested in...



New Supplement Marketer Alliance Creating Multi-Prong PR Campaign

A collaboration of dietary supplement trade groups and individual manufacturers aims to raise $5 mil. to support a multi-year media campaign featuring standard PR, advertising and the Internet.

Red Yeast Rice Safety Advantage Over Rx Statins Cited By UCLA Researcher

Differentiating the metabolic activity of red yeast rice from that of Rx statins could create a "widescale public health prevention" need for botanical supplements unencumbered by the toxicity and safety concerns associated with cholesterol-lowering drugs, according to a University of California at Los Angeles researcher.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092869

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel